Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

NCT00095069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: MK0928, gaboxadol / Duration of Treatment - 1 year
DRUG: Comparator: placebo / Duration of Treatment -1 year

Sponsor

H. Lundbeck A/S